Anti-Bacillus Anthracis PA Therapeutic Antibody (Obiltoxaximab)

Recombinant monoclonal antibody to PA. Obiltoxaximab is a chimeric (mouse/human) monoclonal antibody that can be potentially used in the treatment of Anthrax inhalation.
Supplier Creative Biolabs
Product # TAB-440CQ
Pricing Inquiry
Host Human
Target PA
Species Reactivity Bacillus anthracis
Type IgG1, κ
Applications ELISA, IHC, FC, IP, IF, FuncS
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback